ABBVIE INC

Description

AbbVie Inc is an American pharmaceutical company focused on developing research-based drugs.

It was founded in 2013 as an independent publicly listed company, following a spin-off from Abbott Laboratories.

The company develops, researches, commercializes and sells innovative therapies and medicines.

The global pharma company produces drugs for different therapeutic areas, including:
• chronic kidney disease
• immunology
• women’s health
• Hepatitis C
• neuroscience
• oncology

It also provides treatment remedies for diseases like Parkinson’s, Sclerosis, and Alzheimer’s disease.

The pharmaceutical company operates as one segment with a strong presence in over 175 countries across the globe. AbbVie Inc also owns and operates warehouses, distribution and manufacturing facilities in different geographies such as the United States, European Union, Emerging Markets and Japan.

It markets the pharmaceutical products through a network of distributors, wholesalers, health care facilities, independent retailers, government agencies and specialty pharmacies.

The product pipeline consists of the following drugs:
• Humira
• Celexa
• Depakote
• Duopa
• LEXAPRO
• Namzaric
• Savella
• Viibryd
• Venclexta
• Norvir
• Alora
• Nimbex

In addition, it claims to serve more than 57 million people annually. Its research and development facilities are located in around 20 countries worldwide.

In addition to providing research-driven biopharmaceutical products, AbbVie Inc attempts to develop specialty therapies to address serious and chronic diseases.

The company manufactures several drugs and therapies, which are individually approved by different countries for indicated use and availability.

The other therapeutic areas include:
• Medical Aesthetics
• Eyecare
• Gastroenterology
• Virology
• Neuroscience

The pharma company’s ‘myAbbVie Assist Patient Program’ helps customers with information on medicines, availability, price, etc.

In May 2020, with the acquisition of Allergen plc, the company claimed to have created a diversified entity with a leadership position in core therapeutic areas and the addition of Allergen’s assets and expertise.

AbbVie’s domestic and foreign subsidiaries include Pharmacyclics LLC, AbbVie GK, Keller Medical Inc, Stemcentrx INC, ZELTIQ Aesthetics, Allergan Costa Rica SRL, Repros Therapeutics, Vitae Pharmaceuticals, etc.